MYC Monoclonal Antibody.
Myc tag is a polypeptide protein tag derived from the c-myc gene product that can be added to a protein. It can help to separate recombinant, overexpressed protein from wild type protein expressed by the host organism. Myc Tag also can be used to isolate protein complexes with multiple subunits. The Myc Tag Antibody is produced by the conjugation of a synthetic Myc tag peptide to KLH.
Rapid and precise analysis - less than 2 hours from collected samples to results.
Quick and easy setup procedure - 20 min of hands on time for evaluating 96 patient samples.
No need for purchasing equipment - compatible with all current qPCR platforms (4 Fluorescent Channels).
Quality by Design - flag saples with low cellularity through beta-Actin internal control reducing false negative results.
Over 130 HPV types have been documented in literature, approximately 40 of which infect the anogenital area and are sexually transmitted. Persistent anogenital high risk HPV infection is associated with the majority of cervical cancers. Cervical cancer is highly preventable when cytological and HPV screening programs are employed to facilitate early detection and treatment of pre-cancerous lesions. Of the sexually transmitted HPV genotypes, 14 (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) are considered high risk as they lead to cervical cancer or anogenital warts. In addition, HPV types 6 and 11 are considered low risk for cervical cancer, however they are the cause of 90% of all cases of genital warts as well as respiratory papillomatosis. The GeneNav™ HPV Complete qPCR Kit is a single tube system which utilizes quantitative PCR (qPCR) technology to detect the 16 HPV types described. This kit is able to simultaneously detect the presence of HPV 16 or HPV 18, one of the other high risk HPV subtypes, and HPV 6 or 11.